TrialBreast cancer research and treatment2026

Neoadjuvant therapy with an aromatase inhibitor and durvalumab in postmenopausal patients with hormone receptor-positive breast cancer.

Aixa E Soyano Muller et al.PubMed ↗Publisher ↗

No numbers read from the abstract.